Safety Study to Assess AFM11 in Patients With Relapsed and/or Refractory CD19 Positive B-cell NHL

Clinical trial NCT02106091 · TERMINATED

Trial details

NCT number: NCT02106091
Sponsor: Affimed GmbH
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed B-Cell Non-Hodgkin Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma

Start date: 2014-04-01
Primary completion: 2018-08-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.